ClinicalTrials.gg
CompletedNCT03988153Updated Jun 18, 2019

Efficacy of Probiotic Milk Formula on Blood Lipid and Intestinal Function

A Phase 1 interventional study of Probiotic Milk Formula in Healthy, sponsored by Chung Shan Medical University. Completed. Open to participants aged 18 Years to 60 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2019-06-18.

Sponsored by Chung Shan Medical University · Phase 1, Interventional, and Treatment

From the registry’s dates

  • Registered 8 years 7 months after the study started (first participant enrolled Nov 2010, registered Jun 2019).
Phase
Phase 1
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
18 Years to 60 Years
Sex
All
01

Study summary

Probiotic contained milk formula (PMF) intervention for 10 weeks considerably improves gastrointestinal function by modulating fecal movement, intestinal microflora as well as decrease cholesterol and thus help in the management of hypercholesterolemia.

Read the detailed description

Current randomized placebo-controlled, double-blind was designed to assess the effect of probiotic contained milk formula (PMF) on lipid profile and intestinal function in healthy mild hypercholesterolemic subjects. Totally forty healthy mild hypercholesterolemic subjects (180-220 mg/dL) were randomly chosen and divided into two groups as placebo or experimental group. All the subjects were requested to drink either PMF (experimental) or skimmed milk drink formula-Placebo (30 gm mixed with 200 mL of water) for 10 weeks and continued by 2 weeks of the follow-up period. Supplementation of PMF for 10 weeks significantly improved (p\< 0.05) the fecal weight, fecal movement (decreased fecal GI passing time) by improving intestinal microflora (increasing beneficial bacterial species like Lactobacillus, Bifidobacterium spp) and Lag time of LDL oxidation. In addition, intake of PMF substantially reduced (p\< 0.05) the levels of total cholesterol (TC) and low-density lipoprotein cholesterol (LDL-c) and thus showcasing its cardioprotective efficacy. Therefore PMF is recommended for the management of hypercholesterolemia.

02

Conditions studied

  • Healthy

Keywords

  • Probiotics
  • cholesterol
  • LDL-c
  • Hypercholesterolemic
  • Fecal movement
03

In context

Lead sponsor

Chung Shan Medical University is the lead sponsor of 125 studies on the registry; 25 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • healthy mild hypercholesterolemic subjects (180-220 mg/dL)

Exclusion criteria

Exclusion Criteria:

  • Subjects who took antibiotics or supplements (vitamins or minerals), probiotics (especially dairy products), Subjects suffering from severe gastrointestinal, cardiovascular, hepatic or renal disorders, Lactating or pregnant women, chain smokers.
05

Study design

Phase
Phase 1
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Care provider)
Enrollment
40 participants (actual)

Study arms

  • Experimental
    Probiotic Milk Formula (PMF)

    Twenty subjects should drink 200 mL of PMF (30 gm mixed with 200 mL of water) before breakfast and dinner (2 times/day) for 10 weeks

    Combination Product: Probiotic Milk Formula

  • Placebo comparator
    Skimmed Milk Formula

    Twenty subjects should drink 200 mL of skimmed milk drink (30 gm mixed with 200 mL of water) before breakfast and dinner (2 times/day) for 10 weeks

    Combination Product: Probiotic Milk Formula

Interventions

  • Combination productProbiotic Milk Formula

    Drink 200 mL of PMF for 10 weeks and followed by 2 weeks of follow up period for monitor any adverse effect

06

What researchers measure

Primary outcomes

  1. Fecal Characteristics

    Intervention with PMF to check the change in fecal weight (mg)

    Time frame: 12 weeks

  2. Intestinal microflora

    Intervention with PMF to check the change in fecal Lactobacillus spp content (1 mg)

    Time frame: 12 weeks

Secondary outcomes

  1. Lipid profile

    Intervention with PMF to check the changes in total cholesterol (mg/dl)

    Time frame: 12 weeks

  2. Lag time of LDL oxidation

    Intervention with PMF to check the LDL oxidation time (minutes)

    Time frame: 12 weeks (5 min incubation)

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 18, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03988153
Responsible party
Chin Kun Wang (Professor, Chung Shan Medical University) — Principal investigator
First posted
Jun 17, 2019
Start date
Nov 10, 2010
Primary completion
Mar 15, 2011
Completion
Apr 20, 2011
Last update
Jun 18, 2019

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion